PLRX - Pliant Therapeutics GAAP EPS of -$0.71 beats by $0.02 August, 07 2025 05:52 PM Pliant Therapeutics Inc. 2025-08-07 17:52:25 ET More on Pliant Therapeutics Pliant ends development of idiopathic pulmonary fibrosis asset bexotegrast Seeking Alpha’s Quant Rating on Pliant Therapeutics Historical earnings data for Pliant Therapeutics Financial information for Pliant Therapeutics For further details see: Pliant Therapeutics GAAP EPS of -$0.71 beats by $0.02